ÌÇÐÄÔ­´´

The largest liver study in the history of the NHS is due for roll out next year, with the aim of preventing thousands of people at risk of liver disease from needing hospital care.

A groundbreaking new study, led by experts at the ÌÇÐÄÔ­´´, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout.

A new research project will look at how natural therapies work within the human body.

Experts in respiratory medicine have received funding to better understand how mucus is controlled in the lungs and how it contributes to severe asthma.

A ÌÇÐÄÔ­´´ technical specialist has been recognised by one of the UK’s most prestigious photography awards, with his work selected for nationwide public display as part of Britain’s largest annual photography exhibition.

Scientists from the ÌÇÐÄÔ­´´ are part of an international group of experts who have used cutting edge genomic technology to predict which koalas are at high risk of getting cancer, based on which retroviruses they inherited in their genes.

Shard Diagnostic has become the latest company to join the ÌÇÐÄÔ­´´â€™s investment portfolio, supported through Nottingham Technology Ventures – the university’s wholly owned subsidiary responsible for managing its spin-out portfolio and related inves

Scientists from the ÌÇÐÄÔ­´´ are part of an international collaboration which has taken a step closer to understanding why bacteria can become resistant to antibiotics

The iCAhREâ„¢ (Interdisciplinary Clinical Academic health Research Excellence) programme helps staff at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust to learn about research and use it to further improve patient care.

A dedicated fundraiser and breast cancer survivor has donated a specially designed garden to the Nottingham Breast Cancer Research Centre (NBCRC).